Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohkawara, S.
Right arrow Articles by Hino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohkawara, S.
Right arrow Articles by Hino, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
© 2005 American Society for Nutrition J. Nutr. 135:2878-2883, December 2005


Nutrition and Cancer

Oral Administration of Butyrivibrio fibrisolvens, a Butyrate-Producing Bacterium, Decreases the Formation of Aberrant Crypt Foci in the Colon and Rectum of Mice1,2

Sou Ohkawara, Hideki Furuya, Kousuke Nagashima, Narito Asanuma and Tsuneo Hino3

Department of Life Science, College of Agriculture, Meiji University, Higashimita, Tama-ku, Kawasaki 214-8571, Japan

3To whom correspondence should be addressed. E-mail: hino{at}isc.meiji.ac.jp.

ABSTRACT

Butyrivibrio fibrisolvens, a butyrate-producing ruminal bacterium, was evaluated for use as a probiotic to prevent colorectal cancer. Oral administration to Jcl:ICR mice of a new strain of B. fibrisolvens (MDT-1) that produces butyrate at a high rate (109 cfu/dose) increased the rate of butyrate production by fecal microbes, suggesting that MDT-1 can grow in the gut. The number of colorectal aberrant crypt foci (ACF), putative preneoplastic lesions induced by 1,2-dimethylhydrazine, was reduced after MDT-1 administration (109 cfu/dose, 3 times/wk for 4 wk). The number of aberrant crypts (ACs), number of foci having 3 or 4 ACs per focus, and the percentage of mice having 3 or 4 ACs per focus were also reduced, suggesting that the progress of lesions was suppressed by MDT-1. Interestingly, the MDT-1 cell homogenate did not have a similar beneficial effect. MDT-1 had low ß-glucuronidase activity, and administration of MDT-1 reduced the ß-glucuronidase activity in the colorectal contents. The numbers of natural killer (NK) and NKT cells in the spleen were markedly enhanced in response to MDT-1. Decreased ß-glucuronidase activity and increased numbers of NK and NKT cells and butyrate production may explain in part why MDT-1 administration suppressed ACF formation. These results suggest that colorectal cancer may be prevented or suppressed by the utilization of MDT-1 as a probiotic. Administration of MDT-1 had no harmful effect on the health of mice at least for 3 mo.


KEY WORDS: • Butyrivibrio fibrisolvens • intestinal bacteria • probiotic • colon cancer • butyrate




This article has been cited by other articles:


Home page
J ANIM SCIHome page
M. S. Gomez-Conde, J. Garcia, S. Chamorro, P. Eiras, P. G. Rebollar, A. Perez de Rozas, I. Badiola, C. de Blas, and R. Carabano
Neutral detergent-soluble fiber improves gut barrier function in twenty-five-day-old weaned rabbits
J Anim Sci, December 1, 2007; 85(12): 3313 - 3321.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Ohkawara, H. Furuya, K. Nagashima, N. Asanuma, and T. Hino
Effect of Oral Administration of Butyrivibrio fibrisolvens MDT-1 on Experimental Enterocolitis in Mice
Clin. Vaccine Immunol., November 1, 2006; 13(11): 1231 - 1236.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition